Here's Why Everyone's Talking About AstraZeneca Right Now
AstraZeneca (NASDAQ: AZN) is making headlines again, and this time it has nothing to do with the big pharmaceutical company's COVID-19 vaccine. The European Society for Medical Oncology held its annual conference over the weekend and Enhertu, a new breast cancer drug from AstraZeneca and Daiichi Sankyo (OTC: DSNKY) has the international medical community buzzing with excitement.
Why's everyone talking about the latest set of clinical trial results from AstraZeneca and Daiichi Sankyo? Read on to find out.
Image source: Getty Images.
Source Fool.com
